MFOHome About Commentary Discussions Funds The Best Resources Support Us!

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sign In Register

Categories

In this Discussion

  • bee September 2014
Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Biotechnology ETFs Prove Robust In August

TedTed
in Fund Discussions
FYI: Sell in May and go away? Not with this summer's hot action.

In August, investors dumped ETFs that short the stock market — and picked up a healthy shot of gains from biotechnology funds.
Regards,
Ted
http://license.icopyright.net/user/viewFreeUse.act?fuid=MTg0MjUyNTY=

Enlarged Graphic: http://news.investors.com/photopopup.aspx?path=webETPbio090314.gif&docId=715631&xmpSource=&width=1000&height=562&caption=&id=715630

Comments

  • beebee
    Related Article from T. Rowe Price:
    Encouraging Signs in the Health Care Industry

    "Usually a defensive sector, healthcare has been a leading performer in recent years. Nevertheless, highflying biotechnology stocks suffered a steep decline earlier this year. Taymour Tamaddon, manager of the Health Sciences Fund, discusses recent trends and the current outlook."

    linked Article:
    Encouraging-Signs-in-the-Health-Care-Industry
Sign In or Register to comment.